Literature DB >> 19099359

Characterizing metabolic inhibition using electrochemical enzyme/DNA biosensors.

Dominic O Hull1, Besnik Bajrami, Ingela Jansson, John B Schenkman, James F Rusling.   

Abstract

Studies of metabolic enzyme inhibition are necessary in drug development and toxicity investigations as potential tools to limit or prevent appearance of deleterious metabolites formed, for example, by cytochrome (cyt) P450 enzymes. In this paper, we evaluate the use of enzyme/DNA toxicity biosensors as tools to investigate enzyme inhibition. We have examined DNA damage due to cyt P450cam metabolism of styrene using DNA/enzyme films on pyrolytic graphite (PG) electrodes monitored via Ru(bpy)(3)(2+)-mediated DNA oxidation. Styrene metabolism initiated by hydrogen peroxide was evaluated with and without the inhibitors, imidazole, imidazole-4-acetic acid, and sulconazole (in micromolar range) to monitor DNA damage inhibition. The initial rates of DNA damage decreased with increased inhibitor concentrations. Linear and nonlinear fits of Michaelis-Menten inhibition models were used to determine apparent inhibition constants (K(I)*) for the inhibitors. Elucidation of the best fitting inhibition model was achieved by comparing correlation coefficients and the sum of the square of the errors (SSE) from each inhibition model. Results confirmed the utility of the enzyme/DNA biosensor for metabolic inhibition studies. A simple competitive inhibition model best approximated the data for imidazole, imidazole-4-acetic acid and sulconazole with K(I)* of 268.2, 142.3, and 204.2 microM, respectively.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19099359      PMCID: PMC2684828          DOI: 10.1021/ac802179s

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  46 in total

Review 1.  Biochemical applications of ultrathin films of enzymes, polyions and DNA.

Authors:  James F Rusling; Eli G Hvastkovs; Dominic O Hull; John B Schenkman
Journal:  Chem Commun (Camb)       Date:  2007-08-30       Impact factor: 6.222

2.  Electrochemiluminescent/voltammetric toxicity screening sensor using enzyme-generated DNA damage.

Authors:  Minjeong So; Eli G Hvastkovs; John B Schenkman; James F Rusling
Journal:  Biosens Bioelectron       Date:  2007-07-28       Impact factor: 10.618

3.  Use of isolated hepatocyte preparations for cytochrome P450 inhibition studies: comparison with microsomes for Ki determination.

Authors:  Hayley S Brown; Anthony Chadwick; J Brian Houston
Journal:  Drug Metab Dispos       Date:  2007-08-27       Impact factor: 3.922

Review 4.  Pharmacokinetics and metabolic drug interactions.

Authors:  Sorin E Leucuta; Laurian Vlase
Journal:  Curr Clin Pharmacol       Date:  2006-01

5.  Electrochemical biosensor featuring a two-enzyme pathway and DNA for screening toxic reactive metabolites of arylamines.

Authors:  Minjeong So; John B Schenkman; James F Rusling
Journal:  Chem Commun (Camb)       Date:  2008-07-18       Impact factor: 6.222

6.  Synergistic metabolic toxicity screening using microsome/DNA electrochemiluminescent arrays and nanoreactors.

Authors:  Sadagopan Krishnan; Eli G Hvastkovs; Besnik Bajrami; Dharamainder Choudhary; John B Schenkman; James F Rusling
Journal:  Anal Chem       Date:  2008-06-19       Impact factor: 6.986

7.  Microsome biocolloids for rapid drug metabolism and inhibition assessment by LC-MS.

Authors:  Besnik Bajrami; Sadagopan Krishnan; James F Rusling
Journal:  Drug Metab Lett       Date:  2008-08

Review 8.  Antiarrhythmics: elimination and dosage considerations in hepatic impairment.

Authors:  Ulrich Klotz
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

9.  Enzyme-DNA biocolloids for DNA adduct and reactive metabolite detection by chromatography-mass spectrometry.

Authors:  Besnik Bajrami; Eli G Hvastkovs; Gary C Jensen; John B Schenkman; James F Rusling
Journal:  Anal Chem       Date:  2008-01-25       Impact factor: 6.986

10.  Electrochemical genotoxicity screening for arylamines bioactivated by N-acetyltransferase.

Authors:  Minjeong So; Eli G Hvastkovs; Besnik Bajrami; John B Schenkman; James F Rusling
Journal:  Anal Chem       Date:  2008-01-12       Impact factor: 6.986

View more
  2 in total

1.  Rapid LC-MS drug metabolite profiling using microsomal enzyme bioreactors in a parallel processing format.

Authors:  Besnik Bajrami; Linlin Zhao; John B Schenkman; James F Rusling
Journal:  Anal Chem       Date:  2009-12-15       Impact factor: 6.986

Review 2.  Recent Advances in Electrochemical Biosensors Based on Enzyme Inhibition for Clinical and Pharmaceutical Applications.

Authors:  Loubna El Harrad; Ilhame Bourais; Hasna Mohammadi; Aziz Amine
Journal:  Sensors (Basel)       Date:  2018-01-09       Impact factor: 3.576

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.